Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Viewpoint
  • Published:

Increasing incidence of thyroid cancer: controversies explored

Abstract

Thyroid cancer is the most common endocrine malignancy and its incidence has been increasing considerably in the past few decades. Many studies have been published providing evidence for this increase; however, why thyroid cancer incidence keeps rising is still debated and there are conflicting reports of factors leading to the increase in its incidence. In this article, Nature Reviews Endocrinology asks four experts their opinions on some of the controversies surrounding the changing trends in thyroid cancer incidence.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Takebe, K. et al. Mass screening for thyroid cancer by ultrasonography [Japanese]. KARKINOS 7, 309–317 (1994).

    Google Scholar 

  2. Thorvaldsson, S. E., Tulinius, H., Björnsson, J. & Bjarnason, O. Latent thyroid carcinoma in Iceland at autopsy. Pathol. Res. Pract. 188, 747–750 (1992).

    Article  CAS  Google Scholar 

  3. SEER Cancer Statistics Review, 1975–2008. National Cancer Institute Surveillance Epidemiology and End Results [online], (2011).

  4. Hughes, D. T., Haymart, M. R., Miller, B. S., Gauger, P. G. & Doherty, G. M. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 21, 231–236 (2011).

    Article  Google Scholar 

  5. Burgess, J. R. Temporal trends for thyroid carcinoma in Australia: an increasing incidence of papillary thyroid carcinoma (1982–1997). Thyroid 12, 141–149 (2002).

    Article  Google Scholar 

  6. Davies, L. & Welch, H. G. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295, 2164–2167 (2006).

    Article  CAS  Google Scholar 

  7. Leenhardt, L., Grosclaude, P., Cherie-Challine, L. & Thyroid Cancer Committee. Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14, 1056–1060 (2004).

    Article  Google Scholar 

  8. Kilfoy, B. A. et al. International patterns and trends in thyroid cancer incidence, 1973–2002. Cancer Causes Control 20, 525–531 (2009).

    Article  Google Scholar 

  9. Colonna, M. et al. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983–2000). Eur. J. Cancer 43, 891–900 (2007).

    Article  CAS  Google Scholar 

  10. Harach, H. R., Franssila, K. O. & Wasenius, V. M. Occult papillary carcinoma of the thyroid. A “normal” finding in Finland. A systematic autopsy study. Cancer 56, 531–538 (1985).

    Article  CAS  Google Scholar 

  11. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19, 1167–1214 (2009).

  12. Ito, Y. et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients. World J. Surg. 34, 28–35 (2010).

    Article  Google Scholar 

  13. Leenhardt, L. et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur. J. Endocrinol. 150, 133–139 (2004).

    Article  CAS  Google Scholar 

  14. Sprague, B. L., Warren Andersen, S. & Trentham-Dietz, A. Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control 19, 585–593 (2008).

    Article  Google Scholar 

  15. Ezaki, H. et al. Analysis of thyroid carcinoma based on material registered in Japan during 1977–1986 with special reference to predominance of papillary type. Cancer 70, 808–814 (1992).

    Article  CAS  Google Scholar 

  16. Mathur, A. et al. Higher rate of BRAF mutation in papillary thyroid cancer over time: a single-institution study. Cancer 117, 4390–4395 (2011).

    Article  CAS  Google Scholar 

  17. Cancer Facts & Figures 2011. American Cancer Society [online], (2011).

  18. SEER Stat Fact Sheets: Thyroid. National Cancer Institute Surveillance Epidemiology and End Results [online], (2012).

  19. Nakamura, T. et al. Statistics of descriptive epidemiology for death of malignant thyroid tumor in Japan [author's translation]. Kosei-no-Shihyo 41, 24–30 (1994).

    Google Scholar 

  20. Mazzaferri, E. L. & Jhiang, S. M. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 97, 418–428 (1994).

    Article  CAS  Google Scholar 

  21. Noguchi, S., Yamashita, H., Uchino, S. & Watanabe, S. Papillary microcarcinoma. World J. Surg. 32, 747–753 (2008).

    Article  Google Scholar 

  22. Cramer, J. D., Fu, P., Harth, K. C., Margevicius, S. & Wilhelm, S. M. Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registry. Surgery 148, 1147–1152 (2010).

    Article  Google Scholar 

  23. Enewold, L. et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiol. Biomarkers Prev. 18, 784–791 (2009).

    Article  Google Scholar 

  24. Ito, Y. et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13, 381–387 (2003).

    Article  Google Scholar 

  25. Ron, E. et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat. Res. 141, 259–277 (1995).

    Article  CAS  Google Scholar 

  26. Dickman, P. W., Holm, L. E., Lundell, G., Boice, J. D. Jr & Hall, P. Thyroid cancer risk after thyroid examination with 131I: a population based cohort study in Sweden. Int. J. Cancer 106, 580–587 (2003).

    Article  CAS  Google Scholar 

  27. Ito, Y. et al. Biological behavior and prognosis of familial thyroid carcinoma. Surgery 145, 100–105 (2009).

    Article  Google Scholar 

  28. Huszno, B. et al. Influence of iodine deficiency and iodine prophylaxis on thyroid cancer histotypes and incidence in endemic goiter area. J. Endocrinol. Invest. 26, 71–76 (2003).

    CAS  PubMed  Google Scholar 

  29. Cardis, E. et al. Risk of thyroid cancer after exposure to 131I in childhood. J. Natl Cancer Inst. 97, 724–732 (2005).

    Article  Google Scholar 

  30. Negri, E. et al. A pooled analysis of case–control studies of thyroid cancer. II. Menstrual and reproductive factors. Cancer Causes Control 10, 143–155 (1999).

    Article  CAS  Google Scholar 

  31. Ron, E. et al. A population-based case–control study of thyroid cancer. J. Natl Cancer Inst. 79, 1–12 (1987).

    CAS  PubMed  Google Scholar 

  32. Leung, A. M., Pearce, E. N. & Braverman, L. E. Perchlorate, iodine and the thyroid. Best Pract. Res. Clin. Endocrinol. Metab. 24, 133–141 (2010).

    Article  CAS  Google Scholar 

  33. Williams, D. Radiation carcinogenesis: lessons from Chernobyl. Oncogene 27 (Suppl. 2), S9–S18 (2008).

    Article  CAS  Google Scholar 

  34. Dal Maso, L., Bosetti, C., La Vecchia, C. & Franceschi, S. Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 20, 75–86 (2009).

    Article  Google Scholar 

  35. Hieu, T. T. et al. Cancer risk after medical exposure to radioactive iodine in benign thyroid diseases: a meta-analysis. Endocr. Relat. Cancer 19, 645–655 (2012).

    Article  CAS  Google Scholar 

  36. American Thyroid Association (ATA) Policy Statement. American Thyroid Association [online], (2012).

  37. Ward, M. H. et al. Nitrate intake and the risk of thyroid cancer and thyroid disease. Epidemiology 21, 389–395 (2010).

    Article  Google Scholar 

  38. Pellegriti, G. et al. Papillary thyroid cancer incidence in the volcanic area of Sicily. J. Natl Cancer Inst. 101, 1575–1583 (2009).

    Article  CAS  Google Scholar 

  39. Eze, O. P., Starker, L. F. & Carling, T. The role of epigenetic alterations in papillary thyroid carcinogenesis. J. Thyroid Res. 2011, 895470 (2011).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ito, Y., Nikiforov, Y., Schlumberger, M. et al. Increasing incidence of thyroid cancer: controversies explored. Nat Rev Endocrinol 9, 178–184 (2013). https://doi.org/10.1038/nrendo.2012.257

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2012.257

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer